Ashish Kacholia Took a Fresh Entry & Bought 5,06,400 Shares of This Laboratory Services Company; Stock Hit 10 Per Cent Upper Circuit on April 11

DSIJ Intelligence-1
/ Categories: Trending, Mindshare
Ashish Kacholia Took a Fresh Entry & Bought 5,06,400 Shares of This Laboratory Services Company; Stock Hit 10 Per Cent Upper Circuit on April 11

The stock is up by 85 per cent from its 52-week low of Rs 144 per share.

On Friday, one of the Top Gainers on BSE, shares of this laboratory services company, hit a 10 per cent upper circuit to Rs 266.20 per share from its previous closing of Rs 244 per share. The stock’s 52-week high is Rs 375 per share and its 52-week low is Rs 144 per share. The shares of the company saw a spurt in volume by more than 3 times on the BSE.

Curious why this stock is trending and locked in the upper circuit with heavy volume? Let's explore the reasons before we unveil its identity.

The stock experienced a rapid increase following the reported acquisition of 5,06,400 shares (5.07 per cent stake) by the renowned investor Ashish Kacholia in the March 2025 BSE shareholding pattern.

The buzzing stock name is QUALITEK LABS LTD.

DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, download the service details here.

About the Company

Qualitek Labs, a NABL ISO / IEC 17025: 2017 accredited laboratory company established in 2018 by industry professionals with over a decade of experience, offers comprehensive testing, inspection, certification, homologation and audit services. With a deep understanding of industry challenges, their expert team provides innovative, leading-edge solutions to the automotive, electrical, aerospace and allied industries through their state-of-the-art infrastructure facilities located in Pune and Bhubaneswar, with ongoing expansion to Noida. Their services extend beyond these core sectors to include defence, metals & metallurgy, environment and water, minerals, food & agriculture and pharma & healthcare.

The company reported net sales of Rs 37.62 crore and net profit of Rs 4.01 crore in FY24. The shares of the company have a PE of 66x, an ROE of 20 per cent and an ROCE of 17 per cent. The company has a market cap of Rs 265.65 crore and has a good return on equity (ROE) track record: 3 Years ROE 30.1 per cent. The stock is up by 85 per cent from its 52-week low of Rs 144 per share. Investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

Rate this article:
3.8

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary11-Apr, 2025

Penny Stocks12-Apr, 2025

Penny Stocks12-Apr, 2025

Multibaggers12-Apr, 2025

Mindshare12-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR